Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 79 Show results per page	View Search Criteria \| Help With Results

Last Modified: 3/30/2007 First Published: 8/1/2000


1.		Phase IIB/III Randomized Chemoprevention Study of Celecoxib in Patients With Superficial Transitional Cell Carcinoma of the Bladder at High Risk for Recurrence

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Prevention				Closed				18 and over				NCI				MDA-ID-99368 NCI-P00-0165, SC-NQ4-99-02-006, NCT00006124

Last Modified: 11/1/2006 First Published: 2/1/2002


2.		Phase II/III Randomized Chemoprevention Study of Celecoxib in Patients With Actinic Keratoses

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Prevention				Closed				18 and over				NCI				UAB-9833 UAB-NQ401A4009, UAB-NQ49902009, NCI-P00-0161, NCI-P01-0197, NCT00027976

Last Modified: 6/12/2007 First Published: 4/1/2000


3.		Phase III Randomized Study of Celecoxib for Prevention of New Sporadic Adenomatous Colorectal Polyps in Patients Who Have Undergone Polypectomy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Closed				30 and over				NCI				BWH-NO1-CN-95015 NYH-CMC-0298-108, SC-IQ4-99-02-005, STRANG-98-008, NCI-P00-0141, NCT00005094

Last Modified: 12/12/2007 First Published: 6/23/2003


4.		Phase III Randomized Study of Irinotecan and Capecitabine Versus Irinotecan, Leucovorin Calcium, and Fluorouracil With Versus Without Celecoxib in Patients With Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				Other				EORTC-40015 NCT00064181

Last Modified: 6/22/2006 First Published: 5/28/2004


5.		Phase III Randomized Study of Adjuvant Celecoxib With Fluorouracil and Leucovorin Calcium in Patients With Curatively Resected Stage III Adenocarcinoma of the Colon

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				Other				EORTC-40023 PETACC-5, NCT00085163

Last Modified: 9/18/2006 First Published: 6/23/2004


6.		Phase III Randomized Chemoprevention Study of Celecoxib in Patients With Resected Stage I Adenocarcinoma of the Colon

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Completed				18 and over				NCI				NSABP-P-3 NCT00087256

Last Modified: 4/11/2008 First Published: 10/21/2006


7.		Phase III Randomized Study of Celecoxib in Genotype-Positive Pediatric Patients With Familial Adenomatous Polyposis

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Completed				10 to 17				NCI				MDA-2006-0040 PFIZER-A3191193, N01-CN-05126-2, NCT00393016


8.		Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Completed				30 and over				Pharmaceutical / Industry				EQ4-00-02-018 A3191107, NCT00141193

Last Modified: 2/1/2001 First Published: 5/1/1998


9.		Phase I/II Randomized Study of Celecoxib for Hereditary Nonpolyposis Colorectal Cancer Patients and Gene Carriers (Summary Last Modified 02/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Prevention				Closed				18 and over				NCI				NCI-98-C-0087

Last Modified: 3/3/2008 First Published: 9/1/2001


10.		Phase I/II Study of External Beam Radiotherapy and Brachytherapy Concurrently With Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 to 85				NCI				RTOG-C-0128 NCT00023660

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute